plerixafor has been researched along with Hematologic Malignancies in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 18 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bijou, F; Chabannon, C; Drillat, P; Grouin, JM; Milpied, N; Mohty, M | 2 |
| Allan, D; Bredeson, C; Hamelin, L; Huebsch, L; Kekre, N; Mallick, R; Martin, L; Maze, D; McDiarmid, S; Sabloff, M; Tay, J; Tinmouth, A; Visram, A | 1 |
| Athanasopoulos, A; Grivas, A; Karakosta, M; Kosma, A; Kosmas, C; Kranidioti, E; Lianos, E; Miltiadous, C | 1 |
| Artz, AS; Brazauskas, R; Chen, YB; Craig, M; Devine, SM; DiPersio, JF; Drexler, RJ; Duong, HK; Fernandez, HF; Hamadani, M; Horowitz, MM; Horwitz, ME; Hosoba, S; Kiefer, DM; Kobusingye, H; Le-Rademacher, J; Litzow, MR; McClune, BL; Miller, JP; Proue, M; Shaw, BE; Waller, EK | 1 |
| Craig, M; Cumpston, A; Hamadani, M; Kanate, AS; Watkins, K | 1 |
| Bandera, A; Gori, A; Incontri, A; Perseghin, P; Pioltelli, PE; Verga, L | 1 |
| Allan, D; Bredeson, C; Huebsch, L; Sheppard, D; Tay, J | 1 |
| Abidi, MH; Al-Kadhimi, Z; Ayash, L; Cronin, S; Deol, A; Jain, T; Lum, LG; Mellert, K; Ratanatharathorn, V; Uberti, JP; Veeraputhiran, M | 1 |
| Kindwall-Keller, T | 1 |
| Chao, N; Chhabra, S; Corbet, K; Costa, L; Gasparetto, C; Green, MM; Horwitz, A; Horwitz, M; Kang, Y; Li, Z; Long, G; Mims, A; Rizzieri, D; Sarantopoulos, S; Stuart, R; Sullivan, KM; Sung, AD; Venkata, JK | 1 |
| Abboud, CN; Cashen, AF; DiPersio, JF; Jiang, SY; Landua, S; Pusic, I; Rettig, MP; Sempek, DS; Smith, AL; Stockerl-Goldstein, KE; Uy, GL; Vij, R; Westervelt, P | 1 |
| Calandra, G; Dunn, A; Fowler, CJ; Hansen, K; Hansen, L; Hayes-Lattin, B; Kovacsovics, T; Lanier, K; Leis, J; Maziarz, RT; Nelson, V | 1 |
| Jantunen, E; Kvalheim, G | 1 |
| De Clercq, E | 1 |
| DiPersio, JF; Fruehauf, S; Hanrahan, J; Ho, AD; Hsu, FJ | 1 |
| Baragaño, M; Guggiari, E; Luksch, R; Madero, L; Massimino, M; Pardeo, M; Schiavello, E; Sevilla, J | 1 |
| Allan, D; Bredeson, C; Sheppard, D; Tay, J | 1 |
| Ahn, HS; Hong, KT; Kang, HJ; Kim, H; Kim, MS; Kim, NH; Lee, JW; Park, KD; Shin, HY | 1 |
| DiPersio, JF; Motabi, IH | 1 |
| Bridger, G; Calandra, G; Devine, H; Devine, SM; Dipersio, JF; Fisher, N; Link, DC; McGlauchlen, K; Rettig, M; Todt, L; Vij, R; Westervelt, P | 1 |
7 review(s) available for plerixafor and Hematologic Malignancies
| Article | Year |
|---|---|
A plerixafor-based strategy allows adequate hematopoietic stem cell collection in poor mobilizers: results from the Canadian Special Access Program.
Topics: Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Autografts; Benzylamines; Canada; Compassionate Use Trials; Cost-Benefit Analysis; Cyclams; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Male; Middle Aged; Young Adult | 2014 |
Peripheral stem cell collection: from leukocyte growth factor to removal of catheter.
Topics: Allografts; Benzylamines; Blood Cell Count; Blood Component Removal; Blood Donors; Bone Marrow; Cyclams; Drug Administration Schedule; Gastrointestinal Diseases; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Histocompatibility Testing; Humans; Peripheral Blood Stem Cell Transplantation; Transplantation, Autologous | 2014 |
Mobilization strategies in hard-to-mobilize patients with lymphoid malignancies.
Topics: Algorithms; Anti-HIV Agents; Antigens, CD34; Benzylamines; Blood Component Removal; Cyclams; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Leukocyte Count; Stem Cell Transplantation; Transplantation, Autologous | 2010 |
Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizers.
Topics: Anti-HIV Agents; Benzylamines; Cyclams; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Receptors, CXCR4; Recombinant Proteins | 2010 |
Relevance and clinical implications of tumor cell mobilization in the autologous transplant setting.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Biomarkers, Tumor; Combined Modality Therapy; Cyclams; Cytokines; DNA, Neoplasm; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Neoplasm, Residual; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Peripheral Blood Stem Cell Transplantation; Polymerase Chain Reaction; Recurrence; Risk; Translocation, Genetic; Transplantation, Autologous; Treatment Outcome | 2011 |
Systematic review of randomized controlled trials of hematopoietic stem cell mobilization strategies for autologous transplantation for hematologic malignancies.
Topics: Antigens, CD34; Benzylamines; Cyclams; Cyclophosphamide; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Transplantation, Autologous | 2012 |
Advances in stem cell mobilization.
Topics: Animals; Benzylamines; Cyclams; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Receptors, CXCR4 | 2012 |
5 trial(s) available for plerixafor and Hematologic Malignancies
| Article | Year |
|---|---|
The choice of in-hospital or home administration for plerixafor injection to poor mobilizers has no adverse consequence on subsequent hematopoietic stem cell harvest.
Topics: Autografts; Benzylamines; Cyclams; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Home Care Services; Peripheral Blood Stem Cell Transplantation; Product Surveillance, Postmarketing; Registries | 2017 |
Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells.
Topics: Adult; Aged; Antigens, CD34; Benzylamines; Cyclams; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Histocompatibility; Humans; Middle Aged; Siblings; Tissue Donors; Transplantation, Homologous; Treatment Outcome | 2019 |
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.
Topics: Adult; Aged; Benzylamines; Case-Control Studies; Chemokine CXCL12; Cyclams; Female; Graft Survival; Hematologic Neoplasms; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Male; Middle Aged; Myeloablative Agonists; Neutrophils; Platelet Count; Receptors, CXCR4; Recovery of Function; Transplantation Conditioning; Young Adult | 2016 |
Rescue from failed growth factor and/or chemotherapy HSC mobilization with G-CSF and plerixafor (AMD3100): an institutional experience.
Topics: Adult; Aged; Antigens, CD34; Benzylamines; Cyclams; Drug Administration Schedule; Drug Therapy, Combination; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Male; Middle Aged; Salvage Therapy; Transplantation, Autologous; Treatment Outcome | 2009 |
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction.
Topics: Adult; Aged; Antigens, CD34; Benzylamines; Chemokine CXCL12; Cyclams; Female; Graft Survival; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Kinetics; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Protein Binding; Receptors, CXCR4; Survival Analysis; Tissue Donors; Transplantation, Homologous | 2008 |
9 other study(ies) available for plerixafor and Hematologic Malignancies
| Article | Year |
|---|---|
Addition of plerixafor to G-CSF is useful to achieve efficient collection even in very poor mobilizers: hope for patients with diminished hematopoietic function.
Topics: Autografts; Benzylamines; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoiesis; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Male; Product Surveillance, Postmarketing | 2017 |
Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers.
Topics: Adolescent; Adult; Aged; Autografts; Benzylamines; Cyclams; Female; Graft Survival; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Male; Middle Aged; Retrospective Studies; Time Factors | 2018 |
Re-mobilization of hematopoietic progenitors for further autografting after prior myelo-ablative high-dose chemotherapy and autologous hematopoietic stem cell transplantation;
Topics: Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Autografts; Benzylamines; Combined Modality Therapy; Cyclams; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Male; Middle Aged; Myeloablative Agonists; Neoplasm Recurrence, Local; Prognosis; Transplantation, Autologous; Young Adult | 2019 |
Salvage bone marrow harvest in patients failing plerixafor-based stem cell mobilization attempt: feasibility and autologous transplantation outcomes.
Topics: Aged; Antigens, CD34; Benzylamines; Blood Platelets; Bone Marrow Cells; Cyclams; Disease Progression; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Transplantation, Autologous; Treatment Failure | 2013 |
Use of CXCR4-antagonist for haematopoietic stem cell mobilization in HIV-infected patients with haematological malignancies.
Topics: Benzylamines; Cyclams; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; HIV Infections; Humans; Male; Middle Aged; Receptors, CXCR4; Treatment Outcome | 2013 |
Successful hematopoietic stem cell collection in patients who fail initial plerixafor mobilization for autologous stem cell transplant.
Topics: Adult; Aged; Benzylamines; Blood Cell Count; Cyclams; Cyclophosphamide; Drug Evaluation; Drug Substitution; Drug Synergism; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Male; Middle Aged; Retrospective Studies; Transplantation, Autologous | 2014 |
Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.
Topics: Anti-HIV Agents; Antigens, CD34; Benzylamines; Blood Component Removal; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Leukocyte Count; Male; Middle Aged; Recombinant Proteins; Retrospective Studies; Stem Cell Transplantation; Transplantation, Autologous | 2008 |
Priming of hematopoietic progenitor cells by plerixafor and filgrastim in children with previous failure of mobilization with chemotherapy and/or cytokine treatment.
Topics: Adolescent; Benzylamines; Child; Compassionate Use Trials; Cyclams; Cytokines; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Male; Recombinant Proteins; Retrospective Studies | 2012 |
Successful mobilization using a combination of plerixafor and G-CSF in pediatric patients who failed previous chemomobilization with G-CSF alone and possible complications of the treatment.
Topics: Adolescent; Benzylamines; Child; Cyclams; Drug Combinations; Drug Synergism; Efficiency; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Male; Retrospective Studies; Treatment Failure | 2012 |